Citations to this article


Persistently activated or tyrosine-phosphorylated STAT3 (pSTAT3) is found in 50% of lung adenocarcinomas. pSTAT3 is found in primary adenocarcinomas and cell lines harboring somatic-activating mutations in the tyrosine kinase domain of EGFR. Treatment of cell lines with either an EGFR inhibitor or an src kinase inhibitor had no effect on pSTAT3 levels, whereas a pan-JAK inhibitor (P6) blocked activation of STAT3 and inhibited tumorigenesis. Cell lines expressing these persistently activated mutant EGFRs also produced high IL-6 levels, and blockade of the IL-6/gp130/JAK pathway led to a decrease in pSTAT3 levels. In addition, reduction of IL-6 levels by RNA interference led to a decrease in tumorigenesis. Introduction of persistently activated EGFR into immortalized breast epithelial cells led to tumorigenesis, IL-6 expression, and STAT3 activation, all of which could be inhibited with P6 or gp130 blockade. Furthermore, inhibition of EGFR activity in multiple cell lines partially blocked transcription of IL-6 and concurrently decreased production and release of IL-6. Finally, immunohistochemical analysis revealed a positive correlation between pSTAT3 and IL-6 positivity in primary lung adenocarcinomas. Therefore, mutant EGFR could activate the gp130/JAK/STAT3 pathway by means of IL-6 upregulation in primary human lung adenocarcinomas, making this pathway a potential target for cancer treatment.


Sizhi Paul Gao ... Bayard Clarkson, Jacqueline F. Bromberg


Total citations by year

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 19 55 32 33 29 26 31 16 1 242
Citation information

Citations to this article in year 2008 (16)

Title and authors Publication Year
Integrins in angiogenesis and lymphangiogenesis
CJ Avraamides, B Garmy-Susini, JA Varner
Nature Reviews Cancer 2008
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
S Grivennikov, M Karin
Cancer Cell 2008
Inciting inflammation: the RAGE about tumor promotion
M Dougan, G Dranoff
Journal of Experimental Medicine 2008
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
B Blechacz, GJ Gores
Hepatology 2008
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
M Kujawski, M Kortylewski, H Lee, A Herrmann, H Kay, H Yu
Journal of Clinical Investigation 2008
A Case of Adenocarcinoma of the Lung with Malignant Pleural Effusion and Elevated Serum IL-6 Levels Successfully Treated with Gefitinib
Y Komaki, T Samukawa, Y Higashi, M Soejima, H Nagahama, H Tsubouchi
Haigan 2008
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family
HM Shepard, CM Brdlik, H Schreiber
Journal of Clinical Investigation 2008
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
M Colomiere, AC Ward, C Riley, MK Trenerry, D Cameron-Smith, J Findlay, L Ackland, N Ahmed
British Journal of Cancer 2008
Paradigm shifts in the cell biology of STAT signaling
PB Sehgal
Seminars in Cell & Developmental Biology 2008
The function of Stat3 in tumor cells and their microenvironment
B Groner, P Lucks, C Borghouts
Seminars in Cell & Developmental Biology 2008
Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops
AF Gazdar, JD Minna
Cancer prevention research (Philadelphia, Pa.) 2008
Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3
U Bharadwaj, M Li, C Chen, Q Yao
Molecular cancer research : MCR 2008
Nitric oxide is a key component in inflammation-accelerated tumorigenesis
SP Hussain, P He, J Subleski, LJ Hofseth, GE Trivers, L Mechanic, AB Hofseth, M Bernard, J Schwank, G Nguyen, E Mathe, D Djurickovic, D Haines, J Weiss, T Back, E Gruys, VE Laubach, RH Wiltrout, CC Harris
Cancer research 2008
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas
PT Tran, AC Fan, PK Bendapudi, S Koh, K Komatsubara, J Chen, G Horng, DI Bellovin, S Giuriato, CS Wang, JA Whitsett, DW Felsher
PloS one 2008
Hypothermia downregulates inflammation but enhances IL-6 secretion by stimulated endothelial cells
A Diestel, J Roessler, F Berger, KR Schmitt
Cryobiology 2008
Cancer related inflammation: The macrophage connection
A Sica, P Allavena, A Mantovani
Cancer Letters 2008